Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.18 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 38 Parkinson's trials, 1 stopped | 0.98 |
| literature PubMed | 46 Parkinson's papers of 3,713 | 0.49 |
| pathways Reactome | 1 pathway; mostly growth signalling | 0.60 |
No case: the score is under the bar. Receipt 2084
Sealed predictions
- FER in dopamine neurons, braak+0.55 (p 0.121) → -0.18 (p 0.638)receipt 2091
Swarm cases
receipt 2091: FER in dopamine neurons, braak
- power
- full sample +0.40 (p 0.103, n 18), 95% CI -0.09 to +0.73. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.40 (p 0.099, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.38 (p 0.125, n 18). could be the mix.
- skeptic
- leave-one-out range +0.33 to +0.57, sign flips 0; without severely affected donors +0.40 (p 0.103, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FER in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts